An immuno-therapy platform in development: AbstimX™
Scientists at Network Immunology Inc. have discovered how to prevent development of inflammatory breast cancer, prevent development of inflammatory colitis, and to treat allergy, all with the same immuno-therapeutic, AbstimX™.
We have seen that a single type of two-component treatment is effective in preventing breast cancer and preventing inflammatory bowel disease in mouse models. Further, the same two-component treatment is an effective treatment of egg white allergy in a mouse model.
Network Immunology welcomes collaborators and accredited investors to be a part of this venture.
For investment information, please contact George Hoffmann at firstname.lastname@example.org.